Rob Davis
Rob Davis is the CEO of Merck & Co., having taken over the operational leadership in 2021 after serving as CFO. Under his guidance, the company has faced challenges related to the performance of its blockbuster drug Keytruda and the HPV vaccine Gardasil, navigating through market uncertainties and striving to maintain investor confidence.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
CEO Rob Davis, who has led the operational business since summer 2021, reported a significant slowdown in revenue growth for Gardasil.
5